Related Experiment Video
Updated: Jul 3, 2026

09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.7K
A consultation and work-up diagnosis protocol for a multicancer early detection test: a case series study
Luu Hong Dang Nguyen1, Ba Linh Tieu1, Thi Thanh Nguyen1
1Gene Solutions, Ho Chi Minh, Vietnam.
Future Science OA
|September 10, 2024
Summary
Multicancer early detection (MCED) tests show promise, but positive results need confirmation. The new SPOT-MAS protocol aids general practitioners in interpreting and managing results from circulating tumor DNA (ctDNA) tests for 5 common cancers.
Area of Science:
- Oncology
- Genomics
- Medical Diagnostics
Background:
- Multicancer early detection (MCED) tests offer potential for improved cancer diagnosis and public health.
- Positive MCED results necessitate confirmation via established cancer diagnostic imaging.
- Challenges exist in interpreting and managing results from novel early detection methods.
Purpose of the Study:
- To develop a standardized consultation and work-up protocol for definitive diagnostic results following MCED testing.
- To create a protocol, named SPOT-MAS, to aid general practitioners in managing MCED test outcomes.
- To facilitate the clinical integration of MCED tests by standardizing post-testing procedures.
Main Methods:
- Development of the SPOT-MAS protocol based on circulating tumor DNA (ctDNA) analysis.
- Alignment of the protocol with professional guidelines and advisory board consensus.
- Demonstration of clinical effectiveness through a series of identified cancer cases.
Main Results:
- The SPOT-MAS protocol standardizes information for general practitioners managing MCED results.
- The protocol aids in accessing, interpreting, and managing results from ctDNA analysis.
- Clinical effectiveness was demonstrated in identifying cancer cases post-MCED testing.
Conclusions:
- The SPOT-MAS protocol empowers healthcare professionals to confidently interpret ctDNA test results.
- The protocol supports the interpretation of results for five common cancer types.
- This work facilitates the clinical integration of MCED tests into standard healthcare practice.

